Acrux Ltd

Australian company unlocks a new era for women's health globally with an innovative delivery system for Female testosterone in women with low libido

Acrux receives $0.55m advance on FY26 R&D Tax Incentive

Half Yearly Report and Accounts

Quarterly Activities/Appendix 4C Cash Flow Report

Divestment of Prilocaine 2.5% and Lidocaine 2.5%, Cream